The impact of Achromobacter xylosoxidans on lung function and hospital admissions in adult patients with cystic fibrosis (CF)

S. Cowman, D. Bilton, K. Gyi, K. Alshafi, W. Banya, M. Hodson (London, United Kingdom)

Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Session: Cystic fibrosis: understanding a complex disease
Session type: E-Communication Session
Number: 478
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Cowman, D. Bilton, K. Gyi, K. Alshafi, W. Banya, M. Hodson (London, United Kingdom). The impact of Achromobacter xylosoxidans on lung function and hospital admissions in adult patients with cystic fibrosis (CF). Eur Respir J 2009; 34: Suppl. 53, 478

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of recurrent growth of aspergillus on lung function in paediatric population with cystic fibrosis (CF)
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011


The effect of transition from a paediatric to adult cystic fibrosis (CF) centre on clinical status and hospital attendance
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016

Ciliary function in paediatric non cystic fibrosis (CF) lung transplant recipients
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009

Prevalence of renal impairment in an adult cystic fibrosis (CF) centre
Source: Eur Respir J 2005; 26: Suppl. 49, 622s
Year: 2005

The diagnosis of cystic fibrosis in adult COPD patients. A survey of 54 patients
Source: Eur Respir J 2001; 18: Suppl. 33, 215s
Year: 2001

Factors affecting lung function in adult cystic fibrosis patients after lung transplantation.
Source: International Congress 2018 – Evolving approaches to differential diagnosis
Year: 2018



A review of 50 cystic fibrosis (CF) patients referred to a UK transplant centre
Source: Eur Respir J 2001; 18: Suppl. 33, 298s
Year: 2001

Progression of lung involvement in patients with cystic fibrosis (CF), assessed by longitudinal respiratory function measurements
Source: Eur Respir J 2002; 20: Suppl. 38, 20s
Year: 2002

Non cystic fibrosis (CF) bronchiectasis (BE): assessment in a district general hospital in a district general hospital
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009

Hyperinflation in adult cystic fibrosis (CF) patients: Clinical and functional correlates
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010

Breathing pattern during rest and exercise in patients with cystic fibrosis (CF), pulmonary fibrosis (PF) and COPD before lung transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 685s
Year: 2005

Patient reported quality of life in advanced cystic fibrosis (CF) lung disease assessed for lung transplantation
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008


High frequency chest wall oscillation (HFCWO) in the treatment of acute pulmonary exacerbation in adult cystic fibrosis (CF) patients
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013


Improved survival at low lung function in cystic fibrosis (CF)
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009

Lung clearance index in adult cystic fibrosis patients: the role of convection-dependent lung units
Source: Eur Respir J 2013; 42: 380-388
Year: 2013



Ventilation distribution is not influenced by structural lung disease in infants with cystic fibrosis (CF) diagnosed following newborn screening (NBS)
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009

Hospital admissions are linked to a poor health related quality of life in patients with non cystic fibrosis bronchiectasis
Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host
Year: 2007


The study of expectant life of St-Petersburg patients with cystic fibrosis (CF)
Source: Eur Respir J 2004; 24: Suppl. 48, 617s
Year: 2004

The impact of genotype on clinical course of cystic fibrosis (CF) in adult patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013